STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[10-Q] ESPEY MFG & ELECTRONICS CORP Quarterly Earnings Report

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
10-Q
Rhea-AI Filing Summary

Espey Mfg. & Electronics (ESP) reported stronger profitability for the three months ended September 30, 2025 despite lower sales. Net sales were $9,092,876 versus $10,443,218 a year ago, while gross profit rose to $3,217,002 as gross margin improved to 35.4% from 26.8%. Operating income was $2,065,736 and other income increased to $491,782 on higher interest income. Net income reached $2,169,836, with EPS of $0.80 basic and $0.76 diluted. Management cites product mix, labor efficiencies, and material savings on major programs, partially offset by higher costs on certain fixed‑price engineering contracts.

Cash generation and backlog were solid. Net cash provided by operating activities was $5,720,090. Cash and cash equivalents were $22,220,227, with investment securities of $24,688,473. Contract liabilities rose to $27,974,103, reflecting advances on specific contracts. The order backlog was approximately $141.1 million, with deliveries spread across fiscal 2026 and later years. Espey paid $1.00 per share in dividends during the quarter (including a $0.75 special) and invested $1,290,569 in plant and equipment, partially reimbursed by a Navy-related funding award.

Positive
  • None.
Negative
  • None.
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

FORM 10-Q

QUARTERLY Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended September 30, 2025

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 1-4383

ESPEY MFG. & ELECTRONICS CORP.

(Exact name of registrant as specified in its charter)

New York Trading Symbol 14-1387171
(State of incorporation) ESP (I.R.S. Employer's Identification No.)

233 Ballston Avenue, Saratoga Springs, New York 12866

(Address of principal executive offices)

518-245-4400

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act

Title of each class Trading Symbol Name of each exchange on which registered
Common Stock $.33-1/3 par value ESP NYSE American

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes       ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Date File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes       ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company:

☐ Large accelerated filer Non-accelerated filer
☐ Accelerated filer Smaller reporting company
  Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes     No

At November 10, 2025, there were 2,935,093 shares outstanding of the registrant's Common stock, $.33-1/3 par value.

 

 

ESPEY MFG. & ELECTRONICS CORP.

Quarterly Report on Form 10-Q

I N D E X

 

PART I FINANCIAL INFORMATION PAGE
       
  Item 1 Financial Statements:  
       
    Balance Sheets - September 30, 2025 (Unaudited) and June 30, 2025 1
       
    Statements of Comprehensive Income (Unaudited) - Three Months Ended September 30, 2025 and 2024 2
       
    Statements of Changes in Stockholders’ Equity (Unaudited) – Three Months Ended September 30, 2025 and 2024 3
       
    Statements of Cash Flows (Unaudited) - Three Months Ended September 30, 2025 and 2024 5
       
    Notes to Financial Statements (Unaudited) 6
       
  Item 2 Management's Discussion and Analysis of Financial Condition and Results of Operations 13
       
  Item 3 Quantitative and Qualitative Disclosures about Market Risk 19
       
  Item 4 Controls and Procedures 19
       
PART II OTHER INFORMATION 20
       
  Item 1 Legal Proceedings 20
       
  Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 20
       
  Item 3 Defaults Upon Senior Securities 20
       
  Item 4 Mine Safety Disclosures 20
       
  Item 5 Other Information 20
       
  Item 6 Exhibits 20
       
  SIGNATURES 21

 

 

 

PART I: FINANCIAL INFORMATION

ESPEY MFG. & ELECTRONICS CORP.

Balance Sheets

September 30, 2025 (Unaudited) and June 30, 2025

 

         
   September 30, 2025   June 30, 2025 
ASSETS        
Cash and cash equivalents  $22,220,227   $18,862,645 
Investment securities   24,688,473    24,717,245 
Trade accounts receivable, less allowance for credit losses of $3,000   6,357,856    7,598,888 
           
Inventories:          
Raw materials   2,167,024    2,120,462 
Work-in-process   634,600    681,334 
Costs related to contracts in process   18,262,149    15,040,253 
Total inventories   21,063,773    17,842,049 
           
Net deferred tax assets   1,309,528    1,202,019 
Prepaid expenses and other current assets   5,090,848    4,933,562 
Total current assets   80,730,705    75,156,408 
           
Property, plant and equipment, net   4,116,026    3,960,156 
Total assets  $84,846,731   $79,116,564 
           
LIABILITIES AND STOCKHOLDERS' EQUITY          
Accounts payable  $3,391,839   $2,641,576 
Accrued expenses:          
Salaries and wages   865,672    1,185,387 
Vacation   544,233    568,078 
ESOP payable   57,528    
 
Other   409,332    594,153 
Payroll and other taxes withheld   152,429    93,456 
Contract liabilities   27,974,103    22,886,404 
Income taxes payable   473,834    298,510 
Total current liabilities   33,868,970    28,267,564 
           
Total liabilities   33,868,970    28,267,564 
           
Commitments and contingencies (See Note 5)   
 
    
 
 
           
Common stock, par value $.33-1/3 per share          
Authorized 10,000,000 shares; Issued 3,129,874 shares as of September 30, 2025  and June 30, 2025. Outstanding 2,933,593 and 2,896,368 shares  as of September 30, 2025 and June 30, 2025, respectively (includes 189,816 and 211,487 Unearned ESOP shares, respectively)
   1,043,291    1,043,291 
Capital in excess of par value   26,511,428    26,331,842 
Accumulated other comprehensive gain   15,153    11,596 
Retained earnings   30,977,620    31,550,390 
    58,547,492    58,937,119 
           
Less:    Unearned ESOP shares   (3,471,747)   (3,471,747)
Cost of 196,281 and 233,506 shares of common stock in treasury as of September 30, 2025 and June 30, 2025, respectively   (4,097,984)   (4,616,372)
Total stockholders’ equity   50,977,761    50,849,000 
           
Total liabilities and stockholders’ equity  $84,846,731   $79,116,564 

 

The accompanying notes are an integral part of the financial statements.

1 

 

ESPEY MFG. & ELECTRONICS CORP.

Statements of Comprehensive Income (Unaudited)

Three Months Ended September 30, 2025 and 2024

 

   September 30, 2025   September 30, 2024 
         
Net sales  $9,092,876   $10,443,218 
Cost of sales   5,875,874    7,642,336 
Gross profit   3,217,002    2,800,882 
           
Selling, general and administrative expenses   1,151,266    1,081,669 
Operating income   2,065,736    1,719,213 
           
Other income          
Interest income   472,360    267,617 
Other   19,422    10,791 
Total other income   491,782    278,408 
           
Income before provision for income taxes   2,557,518    1,997,621 
           
Provision for income taxes   387,682    399,304 
           
Net income  $2,169,836   $1,598,317 
           
Other comprehensive income, net of tax          
Unrealized gain on investment securities   3,557    7,692 
           
Total comprehensive income  $2,173,393   $1,606,009 
           
Net income per share:          
Basic  $0.80   $0.63 
Diluted  $0.76   $0.61 
           
Weighted average number of shares outstanding:          
Basic   2,719,387    2,525,937 
Diluted   2,845,252    2,600,237 
           
           
Dividends per share:  $1.00   $0.25 

 

The accompanying notes are an integral part of the financial statements.

 

2 

 

Espey Mfg. & Electronics Corp.

Statements of Changes in Stockholders' Equity (Unaudited)

Three Months Ended September 30, 2025

 

               Accumulated                     
           Capital in   Other               Unearned   Total 
   Outstanding   Common   Excess of   Comprehensive   Retained   Treasury   Treasury   ESOP   Stockholders’ 
   Shares   Amount   Par Value   (Loss) Gain   Earnings   Shares   Amount   Shares   Equity 
Balance as of June 30, 2025   2,896,368   $1,043,291   $26,331,842   $11,596   $31,550,390    233,506   $(4,616,372)  $(3,471,747)  $50,849,000 
                                              
Comprehensive income:                                             
                                              
Net income                       2,169,836                   2,169,836 
                                              
Other comprehensive income,
net of tax of $747
                  3,557                        3,557 
                                              
Total comprehensive income                                           2,173,393 
                                              
Stock options exercised   37,225         105,146              (37,225)   518,388         623,534 
                                              
Stock-based compensation             74,440                             74,440 
                                              
Dividends paid on common stock
$1.00 per share
                       (2,742,606)                  (2,742,606)
                                              
Balance as of September 30, 2025   2,933,593   $1,043,291   $26,511,428   $15,153   $30,977,620    196,281   $(4,097,984)  $(3,471,747)  $50,977,761 

 

The accompanying notes are an integral part of the financial statements.

3 

 

Espey Mfg. & Electronics Corp.

Statements of Changes in Stockholders' Equity (Unaudited)

Three Months Ended September 30, 2024

 

               Accumulated                     
           Capital in   Other               Unearned   Total 
   Outstanding   Common   Excess of   Comprehensive   Retained   Treasury   Treasury   ESOP   Stockholders’ 
   Shares   Amount   Par Value   Gain   Earnings   Shares   Amount   Shares   Equity 
Balance as of June 30, 2024   2,733,958   $1,043,291   $23,930,428   $6,544   $26,004,790    395,916   $(5,842,988)  $(3,868,093)  $41,273,972 
                                              
Comprehensive income:                                             
                                              
Net income                       1,598,317                   1,598,317 
                                              
Other comprehensive income,
net of tax of $1,615
                  7,692                        7,692 
                                              
Total comprehensive income                                           1,606,009 
                                              
Stock options exercised   10,500         79,227              (10,500)   65,599         144,826 
                                              
Stock-based compensation             101,492                             101,492 
                                              
Dividends paid on common stock
$0.25 per share
                       (633,243)                  (633,243)
                                              
Balance as of September 30, 2024   2,744,458   $1,043,291   $24,111,147   $14,236   $26,969,864    385,416   $(5,777,389)  $(3,868,093)  $42,493,056 

 

The accompanying notes are an integral part of the financial statements.

 

4 

 

ESPEY MFG. & ELECTRONICS CORP.

Statements of Cash Flows (Unaudited)

Three Months Ended September 30, 2025 and 2024

 

   September 30, 2025   September 30, 2024 
Cash Flows from Operating Activities:          
Net income  $2,169,836   $1,598,317 
           
Adjustments to reconcile net income to net cash provided by operating activities:          
Stock-based compensation   74,440    101,492 
Depreciation   117,879    109,381 
ESOP compensation expense   247,344    123,194 
Deferred income tax (benefit) expense   (107,509)   43,792 
Loss on disposal of property, plant and equipment   2,016    
 
           
Changes in assets and liabilities:          
Decrease (increase) in trade accounts receivable   1,241,032    (383,333)
Increase in inventories   (3,221,724)   (191,658)
(Increase) decrease in prepaid expenses and other current assets   (157,286)   238,048 
Increase in accounts payable   750,263    170,683 
Decrease in accrued salaries and wages   (319,715)   (270,980)
(Decrease) increase in vacation accrual   (23,845)   15,102 
Decrease in ESOP payable   (189,816)   (52,871)
(Decrease) increase in other accrued expenses   (184,821)   105,012 
Increase in payroll and other taxes withheld   58,973    2,205 
Increase (decrease) in contract liabilities   5,087,699    (327,812)
Increase in income taxes payable   175,324    108,542 
Net cash provided by operating activities   5,720,090    1,389,114 
           
Cash Flows from Investing Activities:          
Additions to property, plant and equipment   (1,290,569)   (664,351)
Proceeds from grant award   1,014,804    
 
Purchase of investment securities   (6,691,671)   (7,258,418)
Proceeds from sale/maturity of investment securities   6,724,000    7,484,000 
Net cash used in investing activities   (243,436)   (438,769)
           
Cash Flows from Financing Activities:          
Dividends on common stock   (2,742,606)   (633,243)
Proceeds from exercise of stock options   623,534    144,826 
Net cash used in financing activities   (2,119,072)   (488,417)
           
Increase in cash and cash equivalents   3,357,582    461,928 
Cash and cash equivalents, beginning of period   18,862,645    4,351,970 
Cash and cash equivalents, end of period  $22,220,227   $4,813,898 
           
Supplemental Schedule of Cash Flow Information:          
Income taxes paid, net of refunds  $320,813   $250,000 

 

The accompanying notes are an integral part of the financial statements.

 

5 

 

ESPEY MFG. & ELECTRONICS CORP.

Notes to Financial Statements (Unaudited)

 

Note 1. Basis of Presentation

 

In the opinion of management, the accompanying unaudited financial statements contain all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation of the results for such periods. The results for any interim period are not necessarily indicative of the results to be expected for the full fiscal year. Certain information and footnote disclosures normally included in financial statements prepared in accordance with United States Generally Accepted Accounting Principles have been condensed or omitted. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of assets and liabilities. On an ongoing basis, we evaluate our estimates and judgments, including those related to revenue recognition, inventories, income taxes, and stock-based compensation. Specific to inventories, including work-in-process and contracts in process, management evaluates, quarterly, those estimates used in determining the cost to complete for each contract on Espey Mfg. & Electronics Corp.’s (the “Company”) sales backlog. The change in estimates may affect the reported amount of inventories and gross profit in the current or a future period and could result in the Company recording a loss contingency when a loss is determined to be probable and reasonably estimated. Management bases its estimates on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. These financial statements should be read in conjunction with the Company's most recent audited financial statements included in its report on Form 10-K for the year ended June 30, 2025. Certain reclassifications may have been made to the prior year financial statements to conform to the current year presentation.

 

Note 2. Investment Securities

 

FASB Accounting Standards Codification (“ASC”) 820 “Fair Value Measurements and Disclosures” establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

 

Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date.

 

Level 2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

 

Level 3: Significant unobservable inputs that reflect a reporting entity’s own assumptions about the assumptions that market participants would use in pricing an asset or liability.

 

The carrying amounts of financial instruments, including cash and cash equivalents, short term investments, accounts receivable, accounts payable and accrued expenses, approximated fair value as of September 30, 2025 and June 30, 2025 because of the immediate or short-term maturity of these financial instruments.

 

Investment securities at September 30, 2025 and June 30, 2025 consisted of certificates of deposit and municipal bonds. The Company classifies investment securities as available-for-sale which have been determined to be level 1 assets. The cost, gross unrealized gains, gross unrealized losses and fair value of available-for-sale debt securities by major security type at September 30, 2025 and June 30, 2025 are as follows:

 

       Gross   Gross     
   Amortized   Unrealized   Unrealized   Fair 
   Cost   Gains   Losses   Value 
September 30, 2025                
Certificates of deposit  $23,583,000   $
   $
   $23,583,000 
Municipal bonds   1,086,293    19,180    
    1,105,473 
Total investment securities  $24,669,293   $19,180   $
   $24,688,473 
                     
June 30, 2025                    
Certificates of deposit  $23,539,000   $
   $
   $23,539,000 
Municipal bonds   1,163,567    14,678    
    1,178,245 
Total investment securities  $24,702,567   $14,678   $
   $24,717,245 

6 

 

The portfolio is diversified, highly liquid, and primarily consists of investment grade fixed income instruments. At September 30, 2025, the Company did not have any investments in individual securities that have been in a continuous loss position considered to be other than temporary.

 

As of September 30, 2025 and June 30, 2025, the remaining contractual maturities of available-for-sale debt securities were as follows:

 

   Years to Maturity     
   Less than   One to     
   One Year   Five Years   Total 
September 30, 2025               
Available-for-sale  $23,606,976   $1,081,497   $24,688,473 
                
June 30, 2025               
Available-for-sale  $22,933,933   $1,783,312   $24,717,245 

 

Note 3. Net Income per Share

 

Basic net income per share excludes dilution and is computed by dividing net income available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net income per share reflects the potential dilution that could occur if securities or other instruments to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income of the Company. The computation of diluted net income per share did not exclude any options to purchase of our common stock for the three months ended September 30, 2025 and excluded 62,691 shares for the three months ended September 30, 2024 as the effect of including them would have been anti-dilutive. As unearned shares owned by the Company’s sponsored leveraged employee stock ownership plan (the “ESOP”) are released or committed-to-be-released, the shares become outstanding for earnings-per-share computations.

 

The following table sets forth the reconciliation of the numerators and denominators of the basic and diluted earnings per share computations for continuing operations for the three month periods ended September 30:

 

    2025     2024  
Numerator:                
Net income   $ 2,169,836     $ 1,598,317  
Denominator:                
                 
Basic EPS:                
Common shares outstanding, beginning of period     2,896,368       2,733,958  
Unearned ESOP shares     (189,817 )     (211,487 )
Weighted average common shares issued during the period     12,779       3,407  
Weighted average ESOP shares earned during the period     57       59  
Denominator for basic earnings per common shares –                
Weighted average common shares     2,719,387       2,525,937  
                 
Diluted EPS:                
Common shares outstanding, beginning of period     2,896,368       2,733,958  
Unearned ESOP shares     (189,817 )     (211,487 )
Weighted average common shares issued during the period     12,779       3,407  
Weighted average ESOP shares earned during the period     57       59  
Weighted average dilutive effect of stock options     125,865       74,300  
Denominator for diluted earnings per common shares –                
Weighted average common shares     2,845,252       2,600,237  

 

7 

 

Note 4. Stock Based Compensation

 

The Company follows FASB ASC 718-40 “Compensation – Stock Compensation” in establishing standards for the accounting of transactions in which an entity exchanges its equity instruments for goods or services, transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments, or that may be settled by the issuance of those equity instruments. ASC 718 requires that the cost resulting from all share-based payment transactions be recognized in the financial statements based on the fair value of the share-based payment. ASC 718 establishes fair value as the measurement objective in accounting for share-based payment transactions with employees, except for equity instruments held by employee share ownership plans. Included as a reduction to the cost recognized for share-based payments is an estimate for option forfeitures. It is the Company’s policy to estimate expected option forfeitures based on historical experience. Actual forfeitures are adjusted prior to the vesting date if the impact is material.

 

Total stock-based compensation expense recognized in the statements of comprehensive income for the three-month periods ended September 30, 2025 and 2024 was $74,440 and $101,492, respectively, before income taxes. The amount of this stock-based compensation expense related to non-qualified stock options (“NQSOs”) for the three-month periods ended September 30, 2025 and 2024 was $6,817 and $7,059, respectively. The deferred tax benefit related to the NQSOs as of September 30, 2025 and 2024 was $1,432 and $1,482, respectively. The remaining stock option expense in each year related to incentive stock options (“ISOs”) which are not deductible by the Company when exercised, assuming a qualifying disposition, and as such no deferred tax benefit was established related to these amounts.

 

As of September 30, 2025, there was $158,654 of unrecognized compensation cost related to stock option awards that is expected to be recognized as expense over the next 1.25 years, of which $144,986 relates to ISOs and $13,668 relates to NQSOs. The total deferred tax benefit related to these awards is expected to be $2,870.

 

The Company has one employee stock option plan under which options or stock awards may be granted, the 2017 Stock Option and Restricted Stock Plan (the "2017 Plan"), approved by the Company’s stockholders at the Company’s Annual Meeting on December 1, 2017. The Board of Directors may grant options to acquire shares of common stock to employees and non-employee directors of the Company at the fair market value of the common stock on the date of grant. The maximum aggregate number of shares of Common Stock subject to options or awards to non-employee directors is 133,000 and the maximum aggregate number of shares of Common Stock subject to options or awards granted to non-employee directors during any single fiscal year is the lesser of 13,300 and 33 1/3% of the total number of shares subject to options or awards granted in such fiscal year. The maximum number of shares subject to options or awards granted to any individual employee may not exceed 15,000 in a fiscal year. Generally, options granted have a two-year vesting period based on two years of continuous service and have a ten-year contractual life. Option grants provide for accelerated vesting if there is a change in control. Shares issued upon the exercise of options are from those held in Treasury. Options covering 400,000 shares are authorized for issuance under the 2017 Plan. As of September 30, 2025, options covering 200,660 shares have been exercised, options covering 186,871 shares are outstanding, and options covering 12,469 shares remain available for grant after factoring cancelled options, which are eligible to be re-granted. While no further grants of options may be made under the Company’s 2007 Stock Option and Restricted Stock Plan, as of September 30, 2025, 4,050 options were outstanding under such plan of which all are vested and exercisable.

 

ASC 718 requires the use of a valuation model to calculate the fair value of stock-based awards. The Company has elected to use the Black-Scholes option valuation model, which incorporates various assumptions including those for dividend yield, volatility, expected life and interest rates.

 

The table below outlines the weighted average assumptions that the Company used to calculate the fair value of each option award for the three months ended September 30, 2024. There were no options awarded during the three months ended September 30, 2025.

 

   September 30, 2024 
Dividend yield   3.79% 
Company’s expected volatility   33.33% 
Risk-free interest rate   4.35% 
Expected term   5.1 yrs 
Weighted average fair value per share of options granted during the period  $5.40 

8 

 

The Company paid regular cash dividends on common stock of $0.25 per share and paid a special dividend on common stock of $0.75 per share in the three months ended September 30, 2025. During the three months ended September 30, 2024, the Company paid a regular cash dividend on common stock of $0.25 per share. Expected stock price volatility is based on the historical volatility of the Company’s stock. The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the options. The expected option term (in years) represents the estimated period of time until exercise and is based on actual historical experience.

 

The following table summarizes stock option activity during the three months ended September 30, 2025 and 2024:

 

   Employee Stock Option Plans
         Weighted   
   Number of  Weighted  Average   
   Shares  Average  Remaining  Aggregate
   Subject  Exercise  Contractual  Intrinsic
   to Option  Price  Term  Value
Balance at July 1, 2024   322,056   $18.41    6.59    
 
 
Granted   76,500   $21.58    9.77      
Exercised   (10,500)  $13.79    
      
Forfeited or expired   
    
    
      
Outstanding at September 30, 2024   388,056   $19.16    6.98   $4,243,194 
                     
Balance at July 1, 2025   228,146   $19.26    7.30      
Granted   
    
    
      
Exercised   (37,225)  $16.75    
      
Forfeited or expired   
    
    
      
Outstanding at September 30, 2025   190,921   $19.75    7.09   $3,790,995 
Vested or expected to vest at September 30, 2025   181,031   $19.66    7.00   $3,548,364 
Exercisable at September 30, 2025   114,421   $18.32    5.96   $1,359,790 

 

The aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between the closing sale price of the Company’s common stock as reported on the NYSE American on September 30, 2025 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders if all option holders had exercised their options on September 30, 2025. This amount changes based on the fair market value of the Company’s common stock. The intrinsic value of options exercised during the three months ended September 30, 2025 and 2024 was $640,228 and $93,512, respectively.

 

The following table summarizes changes in non-vested stock options during the three months ended September 30, 2025 and 2024:

 

   Weighted Number  Average
   of Shares  Grant Date
   Subject  Fair Value
   to Option  (per Option)
Non-vested at July 1, 2024   147,300   $4.15 
Granted   76,500   $5.40 
Vested   (68,400)  $4.11 
Forfeited or expired   
    
 
Non-vested at September 30, 2024   155,400   $4.78 
           
Non-vested at July 1, 2025   144,400   $4.76 
Granted   
    
 
Vested   (67,900)  $4.03 
Forfeited or expired   
    
 
Non-vested at September 30, 2025   76,500   $5.40 

 

9 

 

Note 5. Commitments and Contingencies

 

The Company from time to time, enters into standby letters of credit agreements with financial institutions primarily relating to the guarantee of future performance on certain contracts. Contingent liabilities on outstanding standby letters of credit agreements aggregated to zero at September 30, 2025 and June 30, 2025. The Company, as a U.S. Government contractor, is subject to audits, reviews, and investigations by the U.S. Government related to its negotiation and performance of government contracts and its accounting for such contracts. Failure to comply with applicable U.S. Government standards by a contractor may result in suspension from eligibility for award of any new government contract and a guilty plea or conviction may result in debarment from eligibility for awards. The government may, in certain cases, terminate existing contracts, recover damages, and impose other sanctions and penalties. As a result of contract audits, the Company will determine a range of possible outcomes and, in accordance with ASC 450 “Contingencies,” the Company will accrue amounts within a range that appears to be its best estimate of a possible outcome. Adjustments are made to accruals, if any, periodically based on current information.

 

We are party to various litigation matters and claims that may arise in the ordinary course of business. Currently, there are no matters pending.

 

The Company received an award for $3.4 million in funding during the second quarter of fiscal year 2025 in support of continued facility and capital equipment upgrades for testing and qualification for the United States Navy. The funding is part of the Navy’s investment to improve and sustain the Surface Combatant Industrial Base. Work is being conducted on the Company’s property in Saratoga Springs, NY, which is anticipated to be completed by the end of fiscal year 2026. The Company will receive payment related to submission of milestone achievement. The first two milestones were achieved upon placement of all purchase orders and subsequently submitted for reimbursement. The final milestone and reimbursement are dependent on completion of all work to be performed and assets purchased to be placed in service. To receive full reimbursement of the $3.4 million award, the Company must invest approximately 15% or $508,000 of company funds over and above the $3.4 million award in relation to these facility improvements and capital equipment upgrades. The Company will record the receipt of milestone payments as a reduction from the cost of the assets. The Company will have an initial cash outlay to satisfy income tax obligations arising from the value of the milestone payments received. The cash outlay arising from federal income tax obligations is expected to be recaptured in future periods. Until recaptured, estimated tax obligations associated with the receipt of milestone payments are recorded on the balance sheet and included in deferred tax assets. As of September 30, 2025, the Company has received $1,014,804 in milestone reimbursements. Included in property, plant, and equipment at September 30, 2025 was approximately $1,852,844, net of reimbursements to date under this funding award, including $614,927 related to assets that have been placed in service. Included in accounts payable at September 30, 2025 was $418,480 for facility and capital upgrades of which $355,641 is eligible to be reimbursed under this funding award.

 

Note 6. Revenue

 

The Company follows FASB ASC 606 “Revenue from Contracts with Customers” to determine the recognition of revenue. This standard requires entities to assess the products or services promised in contracts with customers at contract inception to determine the appropriate unit at which to record revenues. Revenue is recognized when control of the promised products or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those products or services.

 

Significant judgment is required in determining the satisfaction of performance obligations. Revenues from our performance obligations are satisfied over time using the output method which considers the appraisal of results achieved and milestones reached or units delivered based on contractual shipment terms, typically shipping point. Revenue is recognized when, or as, the customer takes control of the product or services. The output method best depicts the transfer of control to the customer as the output method represents work completed. Control is typically transferred to the customer at the shipping point, as the Company has a present right to payment, the customer has legal title to the asset, the customer has the significant risks and rewards of ownership of the asset, and in most instances the customer has accepted the asset. For milestones achieved, the customer has confirmed the performance defined in the contract has been met and the Company is entitled to payment.

10 

 

Total revenue recognized for the three months ended September 30, 2025 based on units delivered was $7,339,223 compared to $8,262,496 for the same period in fiscal year 2025. Total revenue recognized for the three months ended September 30, 2025 based on milestones achieved was $1,753,653 compared to $2,180,722 for the same period in fiscal year 2025. Net sales to five significant customers represented 79.7% of the Company’s total sales for the three-month period ended September 30, 2025. Net sales to three significant customers represented 51.8% of the Company’s total sales for the three-month period ended September 30, 2024. A single customer may participate in multiple active programs. Therefore, the loss of one program does not necessarily result in the loss of the customer relationship.

 

The Company offers a standard one-year product warranty. Product warranties offered by the Company are classified as assurance-type warranties, which means the warranty only guarantees that the good or service functions as promised. Based on this, the provided warranty is not considered to be a distinct performance obligation. The impact of variable consideration has been considered but none identified which would be required to be allocated to the transaction price as of September 30, 2025. Our payment terms are generally 30-60 days.

 

Contract liabilities were $27,974,103 and $22,886,404 as of September 30, 2025 and June 30, 2025, respectively. The increase in contract liabilities is primarily due to the advance collection of cash on specific contracts, offset in part, by revenue recognized. Of the $22,886,404 that was in contract liabilities as of June 30, 2025, $729,350 has been recognized in revenue as of the three months ended September 30, 2025. The Company used the practical expedient to expense incremental costs incurred to obtain a contract when the contract term is less than one year.

 

The Company’s backlog at September 30, 2025 totaling approximately $141.1 million is currently estimated to be recognized in the following fiscal years: 27.6% in 2026; 26.9% in 2027; 16.1% in 2028; 29.4% thereafter. The timing of supplier deliveries of material, production schedules, the completion of engineering deliverables, among other factors, could cause these estimates to change. The contracts that make up the Company’s backlog are enforceable and include cancellation clauses. If a contract is terminated for the convenience of the government, the Company would be entitled to receive payments for our allowable costs and, in general, the proportionate share of fees or earnings for the work done. If a contract is terminated for default, the government generally would pay for only the work it has accepted.

 

Note 7. Recently Issued Accounting Standards

 

Recent Accounting Pronouncements Not Yet Adopted

 

In December 2023, FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” to enhance the transparency and decision usefulness of income tax disclosures. The amendments in ASU 2023-09 provide improvements primarily related to the rate reconciliation and income taxes paid information included in income tax disclosures. The Company would be required to disclose additional information regarding reconciling items equal to or greater than five percent of the amount computed by multiplying pretax income (loss) by the applicable statutory tax rate. Additionally, the Company would be required to disclose income taxes paid (net of refunds received) disaggregated by individual jurisdictions, when the taxes paid in an individual jurisdiction is equal to or greater than five percent of the Company’s total income taxes paid (net of refunds received). The amendments in ASU 2023-09 are effective for the annual period beginning July 1, 2025. The Company will assess the impact of ASU 2023-09 on its financial statements and plans to adopt the standard in its Form 10-K for the fiscal year ending June 30, 2026.

 

In November 2024, the FASB issued ASU 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40)” with the goal of improving disclosures about a public business entity’s expenses and address requests from investors for more detailed information about the types of expenses in captions that are commonly presented on the face of the financial statements such as cost of sales, SG&A, and research and development. These amendments are effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. Early adoption is permitted and should be applied either prospectively to financial statements issued for reporting periods after the effect date of the updates or retrospectively to any or all prior periods presented in the financial statements. The Company will evaluate the impact of this guidance on its financial statements.

 

Recent Accounting Pronouncements Adopted

 

In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” which provides updates to qualitative and quantitative reportable segment disclosure requirements. The amendments in ASU 2023-07 require all public entities, including those with a single reportable segment, to include additional disclosures around significant segment expenses, as well as identify measures used by the Chief Operating Decision Maker in evaluating segment performance, allocating resources, and assessing Company results. Espey adopted ASU 2023-07 effective June 30, 2025. The adoption of 2023-07 did not change the way that the Company identifies its reportable segments and, did not have a material impact on the Company’s segment-related disclosures. Refer to Note 9. Segment Reporting for further information.

11 

 

Note 8. Employee Stock Ownership Plan

 

The Company sponsors a leveraged employee stock ownership plan (the "ESOP") that covers all nonunion employees who work 1,000 or more hours per year and are employed on June 30. The Company makes annual contributions to the ESOP equal to the ESOP's debt service less dividends on unallocated shares received by the ESOP. All dividends on unallocated shares received by the ESOP are used to pay debt service. Dividends on allocated ESOP shares are recorded as a reduction of retained earnings. As the debt is repaid, shares are released and allocated to active employees, based on the proportion of debt service paid in the year. The Company accounts for its ESOP in accordance with FASB ASC 718-40 “Share-based Payments.” Accordingly, the shares purchased by the ESOP are reported as Unearned ESOP shares in the balance sheet and the statement of changes in stockholders’ equity. As shares are released or committed-to-be-released, the Company reports compensation expense equal to the current average market price of the shares, and the shares become outstanding for earnings-per-share (EPS) computations. The ESOP borrowed from the Company an amount equal to the purchase price of the ESOP shares. The current outstanding loan will be repaid in fifteen (15) equal annual installments of principal which commenced June 2021. The unpaid balance bears interest at a fixed rate of 3.00% per annum. ESOP compensation expense was $247,344 and $123,194 for the three-month periods ended September 30, 2025 and 2024, respectively.

 

The ESOP shares as of September 30, 2025 and 2024 were as follows:

 

   September 30, 2025   September 30, 2024 
Allocated shares   374,656    437,201 
Committed-to-be-released shares   5,295    5,417 
Unreleased shares   184,522    206,070 
Total shares held by the ESOP   564,473    648,688 
Fair value of unearned shares  $8,619,023   $6,200,646 

 

The Company may at times be required to repurchase shares at the ESOP participants’ request at the shares’ fair market value. During the three months ended September 30, 2025 and 2024, the Company did not repurchase shares held by the ESOP.

 

The ESOP allows for eligible participants to take whole share distributions from the Plan on specific dates in accordance with the provision of the Plan. Total share distributions from the ESOP during the three months ended September 30, 2025 totaled 30,826, of which 20,985 were liquidated and 9,841 were transferred. Total share distributions from the ESOP during the three months ended September 30, 2024 totaled 14,357, of which 13,931 were liquidated and 426 were transferred.

 

Note 9. Segment Reporting

 

As of June 30, 2025, the Company adopted FASB’s ASU 2023-07 “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures”, which provides enhancements to qualitative and quantitative reportable segment disclosure requirements for all public companies. Operating segments are clearly defined components of an entity in which separate financial information is readily available and reviewed by the chief operating decision maker (“CODM”) when allocating resources and assessing company performance. Espey’s CODM is the Chief Executive Officer. There is one management team that oversees a single operating segment and reports directly to the CEO. Our CODM evaluates performance and makes operating decisions about allocating resources based on financial data as presented on the face of the financial statements, focusing on significant expenses, net income, and certain key performance indicators (“KPI”) presented on our internal monthly and weekly management reports. Significant expenses regularly provided to and reviewed by the CODM are Cost of Sales and Selling, General and Administrative costs which are each separately presented on the Company’s Statement of Comprehensive Income. During each of the quarters ended September 30, 2025 and 2024, domestic revenue accounted for more than 90% of total revenue. The Company manages sales in totality, under one reportable segment.

 

12 

 

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

 

Overview

 

Espey Mfg. & Electronics Corp. (“Espey”) is a power electronics design and original equipment manufacturing (OEM) company with a long history of developing and delivering reliable products for use in military and severe environment applications. Design, manufacturing, and testing is performed in our in-service 174,000+ square foot facility located at 233 Ballston Ave, Saratoga Springs, New York. Espey is classified as a “smaller reporting company” for purposes of the reporting requirements under the Securities Exchange Act of 1934, as amended. Espey’s common stock is publicly-traded on the NYSE American under the symbol “ESP.”

 

Espey began operations after incorporation in New York in 1928. We strive to remain competitive as a leader in high power energy conversion and transformer solutions through the design and manufacture of new and improved products by using advanced and “cutting edge” electronics technologies.

 

Espey is an ISO 9001:2015 and AS9100:2016 certified manufacturer of power conversion, advanced magnetics and “build to print” products where specifications are provided by the customer for the rugged industrial and military marketplace. Our primary products are power supplies, power converters, filters, power transformers, magnetic components, power distribution equipment, UPS systems, and antennas. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.

 

Espey services include design, development, and build to specifications provided by the customer (build to print), design services, design studies, environmental testing services, metal fabrication, painting services, and development of automatic testing equipment. Espey is vertically integrated, meaning that the Company produces individual components (including inductors), populates printed circuit boards, fabricates metalwork, paints, wires, qualifies, and fully tests items, mechanically, electrically and environmentally, in house. Portions of the manufacturing and testing process are subcontracted to vendors on occasion.

 

The Company markets its products primarily through its own direct sales organization and through outside sales representatives. Business is solicited from large industrial manufacturers and defense companies, the government of the United States, foreign governments and major foreign electronic equipment companies. Espey is also on the eligible list of contractors with the United States Department of Defense. We pursue opportunities for prime contracts directly with the Department of Defense and are generally solicited by Department of Defense procurement agencies for their needs falling within the major classes of products produced by the Company. Espey contracts with the Federal Government under cage code 20950 as Espey Mfg. & Electronics Corp.

 

There is competition in all classes of products manufactured by the Company, ranging from divisions of the largest electronic companies to many small companies. The Company's sales do not represent a significant share of the industry's market for any class of its products. The principal methods of competition for electronic products of both a military and industrial nature include, among other factors, price, product performance, the experience of the particular company and history of its dealings in such products.

 

Our business is not seasonal. However, the concentration of our business in the rail industry, equipment for military and industrial applications, and our customer concentrations expose us to on-going associated risks. These risks include, without limitation, fluctuating requirements for power supplies in the rail industry, dependence on appropriations from the United States Government and the governments of foreign nations, program allocations, the potential of governmental termination of orders for convenience, and the general strength of the industry sectors in which our customers transact business.

 

Future procurement needs supporting the military and the rail industry continue to drive competition. Many of our competitors have invested, and continue to invest, aggressively in upfront product design costs and accept lower profit margins as a strategic means of maintaining existing business and enhancing market share. This continues to put pressure on the pricing of our current products and has lowered our profit margins on some of our new business. In order to compete effectively for new business, in some cases we have invested in upfront design costs, thereby reducing initial profitability as a means of procuring new long-term programs. As part of our strategy, we adjust our pricing in order to achieve a balance which enables us both to retain repeat programs while being more competitive in bidding on new programs.

 

13 

 

Our sales strategy includes identifying and obtaining multiple new engineering design and development contracts in any given fiscal year to ensure optimal utilization of our engineering personnel in addition to securing follow-on production awards for product previously designed in-house, as well as, new or follow-on build to print opportunities. The Company targets those programs and opportunities which will generate future longer-term production tails in ensuing years. From time to time, we accept work associated with engineering design studies. While unlikely to result in near-term follow-on orders, this positions us competitively for future awards and expands our engineering team’s skillset.

 

The total backlog at September 30, 2025 was approximately $141.1 million, which included $92.3 million from three significant customers, compared to approximately $94.6 million at September 30, 2024, which included $58.0 million from four significant customers. A single customer may participate in multiple active programs. Therefore, the loss of one program does not necessarily result in the loss of the customer relationship. For this reason, management believes that the customer backlog concentration poses minimal risk to the Company. The Company’s total backlog represents the estimated remaining sales value of work to be performed under firm contracts. It is not uncommon to receive orders which include delivery schedules extending beyond a year from the contract purchase date. Accordingly, a customer’s future reorder point may vary. The backlog at September 30, 2025 is fully funded, except for approximately $26 million, the majority of which represents amounts under multiple orders from a single customer. While there is no guarantee that future budgets and appropriations will provide funding for individual programs, management has included in the unfunded backlog only those programs that it believes are likely to receive funding based on program status and discussions with customers. Contracts are subject to modification, change or cancellation, and the Company accounts for these changes as they are probable and estimable. The Company evaluates the impact of any scope modifications and will adjust reserves to the extent information is known or estimable. Contracts are generally not cancellable without penalty or recourse.

 

Management expects revenues to be higher in fiscal year 2026 than fiscal year 2025. This expectation is driven primarily by orders already in our backlog that are expected to be shipped before the end of fiscal year 2026. Following the review of the first quarter results, management believes that net income for fiscal year 2026 will approximate net income from fiscal year 2025. The Company does not anticipate that the government shutdown will have an adverse effect on future financial performance. However, the ultimate impact of such events is inherently uncertain and beyond the Company’s control, and actual results could differ from current expectations.

 

From time to time, we encounter part obsolescence which requires us to identify an alternate part suitable for use. We continue to work with our customers on strategies to mitigate any adverse impact upon our ability to service their requirements. Factors which may arise after the placement of the customer’s order may cause us to miss projected delivery dates. Inflationary costs are expected to continue, but are not expected to have a significant impact on operating income in fiscal year 2026. Tariffs on steel and aluminum imports from various countries remain in effect and, while not directly imposed on the Company, have contributed to higher costs from suppliers. Although we are not currently experiencing any significant financial or raw material sourcing issues resulting from the product tariffs, the Company cannot provide any assurance that the existing tariffs, the potential of additional tariffs, and the associated volatility arising from foreign trade policies, will not have a negative impact on our future earnings.

 

The labor workforce remains stable. Management continues to closely monitor workforce labor requirements to support our sales backlog and planned delivery schedules. Longer time-to-hire challenges remain for certain positions due to specific skillsets required for those positions. Unemployment rates in the local geographic region trend lower than the national average which has created a competitive recruiting environment. Where possible, the Company continues to offer on-the-job training and when necessary, continues to recruit personnel outside the local region. Combined with supply chain constraints, unforeseen labor disruptions could delay shipments and result in missing our backlog fulfillment projections and recognizing lower than anticipated operating income.

 

Successful conversion of engineering program backlog into sales is largely dependent on the execution and completion of our engineering design efforts. It is not uncommon to experience technical or scheduling delays which arise from time to time as a result of, among other reasons, design complexity, the availability of personnel with the requisite expertise, and the requirements to obtain customer approval at various milestones. Cost overruns which may arise from technical and scheduling delays and increased raw material costs could negatively impact the timing of the conversion of backlog into sales, or the profitability of such sales. Engineering programs in both the funded and unfunded portions of the current backlog aggregate $11.8 million.

 

14 

 

It is presently anticipated that a minimum of $38.9 million of orders comprising the September 30, 2025 backlog will be filled during the fiscal year ending June 30, 2026 subject, however, to the impact of the factors identified above. The minimum of $38.9 million does not include any shipments which may be made against orders subsequently received during the fiscal year ending June 30, 2026.

 

The Company currently expects new orders in fiscal year 2026 to be lower than those received in fiscal year 2025. During fiscal year 2025, the Company received $86.4 million in new orders which included two significant, multi-year contract awards in an aggregate sum of $49.4 million. New orders received in the first three months of fiscal year 2026 were approximately $10.5 million as compared to $7.8 million of new orders received in the first three months of fiscal year 2025. In addition to the backlog, the Company currently has outstanding opportunities representing approximately $161.5 million in the aggregate as of November 10, 2025, for both repeat and new programs. Outstanding opportunities encompass various new and previously manufactured power supplies, transformers, and subassemblies. The stated amount includes only those opportunities that we believe are likely to be awarded based on factors which include: quotation status, communicated award dates, historical ordering, public information on defense programs and program funding, discussion with customers, and our cost competitiveness. However, there can be no assurance that the Company will acquire any of the outstanding opportunities described above, many of which are subject to allocations of the United States defense spending and elements affecting the defense industry. Many solicitations we receive for the procurement of goods and services takes place by competitive bidding.

 

Historically, a small number of customers have accounted for a large percentage of the Company’s total sales in any given fiscal year. Management continues to pursue opportunities with current and new customers with an overall objective of lowering the concentration of sales, mitigating excessive reliance upon a single major product of a particular program and minimizing the impact of the loss of a single significant customer. As previously stated above, a single customer may participate in multiple active programs. Therefore, the loss of one program does not necessarily result in the loss of the customer relationship. For this reason, management believes that sales concentration poses minimal risk to the Company. Given the nature of our business, we believe our existing sales order backlog is fairly diversified in terms of customers and the category of products on order.

 

Critical Accounting Policies and Estimates

 

The preparation of our financial statements in accordance with Generally Accepted Accounting Principles requires management to make certain judgments, estimates, and assumptions that affect the reported amounts as presented on the face of the financial statements. These critical accounting policies and estimates are those that are most important to the portrayal of our financial condition and results of operations. We base our estimates on historical experience and other assumptions that we believe to be reasonable. Management continually reviews and evaluates these critical accounting policies and estimates in light of evolving business conditions, regulatory developments, and changes in the economic environment. As future events cannot be determined and their impact on the financial statements are uncertain, actual results may differ from our estimates and could be material to the financial statements. Historically, we have found our application of accounting policies to be appropriate, and actual results have not differed materially from established estimates. The critical accounting policies and estimates that we believe have the most significant effect on our financial statements are revenue recognition, inventory valuation, and deferred taxes.

 

Revenue Recognition

 

The majority of our sales are generated from military contracts from defense companies, the Department of Defense, other agencies of the government of the United States and foreign governments. We provide our products and design and development services under fixed-price contracts. Under fixed-price contracts we agree to perform the specified work for a pre-determined price. To the extent our actual costs vary from the estimates upon which the price was negotiated, our generated profit will fluctuate or a loss could be incurred.

 

15 

 

We evaluate the products or services promised in each contract at inception to determine whether the contract should be accounted for as having one or more performance obligations. Significant judgment is required in determining performance obligations. We determine the transaction price for each contract based on the consideration we expect to receive for the products or services being provided under the contract. As the Company does not have standalone observable prices, a contract’s transaction price of each performance obligation is based on the standalone selling price, which is determined using an expected cost plus a margin approach.

 

We account for a contract with a customer after it has been approved by all parties to the arrangement, the rights of the parties are identified, payment terms are identified, the contract has commercial substance, and collection of substantially all of the amount to which the entity will be entitled in exchange for the goods or services that will be transferred to the customer is probable. We assess each contract at its inception to determine whether it should be combined with other contracts. When making this determination, we consider factors such as whether two or more contracts were negotiated and executed at or near the same time, or were negotiated with an overall profit objective.

 

We recognize revenue using the output method based on the appraisal of results achieved and milestones reached or units delivered based on contractual shipment terms, typically shipping point.

 

Inventory Valuation

 

Raw materials are valued at the lower of cost (average cost) or net realizable value. Balances for slow-moving and obsolete inventory are reviewed on a regular basis by analyzing estimated demand, inventory on hand, sales levels, market conditions, and other information. Inventory balances are reduced based on this analysis.

 

Inventoried work relating to contracts in process and work-in-process is valued at actual production cost, including factory overhead incurred to date. Contract costs include material, subcontract costs, labor, and an allocation of overhead costs. Work-in-process represents spare units and parts and other inventory items acquired or produced to service units previously sold or to meet anticipated future orders. Provision for losses on contracts is made when the existence of such losses becomes probable and estimable. The provision for losses on contracts is included in other accrued expenses on the Company’s balance sheet. The costs attributed to units delivered under contracts are based on the estimated average cost of all units expected to be produced. Certain contracts are expected to extend beyond twelve months.

 

The estimation of total cost at completion of a contract is subject to numerous variables involving contract costs and estimates as to the length of time to complete the contract. Given the significance of the estimation processes and judgments described above, it is possible that materially different amounts of expected sales and contract costs could be recorded if different assumptions were used, based on changes in circumstances, in the estimation process. When a change in expected sales value or estimated cost is determined, the change is reflected in current period earnings.

 

Deferred Taxes

 

The Company follows the provisions of the Financial Accounting Standards Board (“FASB”), Accounting Standards Codification (ASC) Topic 740-10, “Accounting for Income Taxes."

 

Under the provisions of FASB ASC 740-10, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred taxes and liabilities of a change in tax rates is recognized in earnings in the period that includes the enactment date.

 

Contract Liabilities

 

Contract liabilities include advance payments and billings in excess of revenue recognized.

 

Accounts Receivable and Allowance for Credit Losses

 

The Company extends credit to its customers in the normal course of business and collateral is generally not required for trade receivables. Exposure to credit risk is controlled through the use of credit approvals, credit limits, and monitoring procedures. The accounts receivable balance is reported net of an allowance for credit losses. The Company estimates the allowance based on its analysis of historical experience, current economic market conditions, performance of specific account reviews, and other factored considerations to include, but not limited to, contracts covered by government funding and the overall health of the industry. Interest is not charged on past due balances. Based on these factors, there was an allowance for credit losses of $3,000 at September 30, 2025 and June 30, 2025. Changes to the allowance for credit losses are charged to expense and reduced by charge-offs, net of recoveries. The opening accounts receivable balance, net of allowance for credit losses of $3,000, at July 1, 2024 and July 1, 2025 were $6,635,490 and $7,598,888, respectively.

 

16 

 

Results of Operations

 

Net sales for the three months ended September 30, 2025 and 2024 were $9,092,876 and $10,443,218, respectively, a 12.9% decrease. In general, sales fluctuations may occur during comparable fiscal periods as the direct result of sales backlog levels, product mix, and specific contractual terms of those firm orders placed including contract value, scope of work, and contract delivery schedules.

 

For the three months ended September 30, 2025, the decrease in sales when compared to the same period last year is primarily due to less deliveries and milestones met during the quarter due to the product mix comprising those shipments and milestones. The decrease in sales in the current year was mainly related to a few specific programs for our magnetics, power supply and build to print product groups. During the current quarter, sales declined due to the completion of a key build-to-print program that we saw in the prior comparable period and reduced deliveries on a power supply contract compared to the same quarter last year. Additionally, we saw a decrease in deliveries for a key multi-year magnetics program when compared to the first quarter in fiscal year 2024. These decreases were partially offset by the increase in sales on core power supply, magnetics, and build-to-print programs, different from those mentioned above. These decreases are attributable to the timing of shipments on certain programs. The decline in sales during the first quarter primarily reflects the timing of shipments on select programs and is not indicative of a sustained change in overall sales trends or order volume.

 

Gross profits for the three months ended September 30, 2025 and 2024 were $3,217,002 and $2,800,882, respectively. Gross profit as a percentage of sales was approximately 35.4% and 26.8%, for the same periods, respectively. The increase in gross margin percentage for the three months ended September 30, 2025, was primarily driven by product mix, labor cost efficiencies, and negotiated savings on material purchases for major power supply programs, as well as effective management of field support and subcontracting costs. The improvement in gross profits in the first quarter of fiscal year 2026 compared to the prior year, was partially offset by unanticipated costs on certain fixed-price engineering design contracts for power supplies, arising from unforeseen complexities in the designs.

 

The primary factors in determining the change in gross profit and net income are overall sales levels and product mix. The gross profits on mature products and build to print contracts are typically higher as compared to products which are still in the engineering development stage or in early stages of production. In the case of the latter, the Company can incur what it refers to as “loss contracts,” primarily on engineering design contracts in which the Company invests with the objective of developing future product sales. In any given accounting period the mix of product shipments between higher margin programs, less mature programs, and expenditures associated with loss contracts, has a significant impact on gross profit and net income.

 

Selling, general and administrative expenses were $1,151,266 for the three months ended September 30, 2025, an increase of $69,597, compared to the three months ended September 30, 2024. The slight increase in spending for the three months ended September 30, 2025 as compared to the same period last year relates to the increase in employee compensation costs, facility costs, and outside selling costs related to non-employee sales representatives. These increases were partially offset by a decrease in officer compensation, stock option expense, and shipping costs.

 

Other income for the three months ended September 30, 2025 and 2024 was $491,782 and $278,408, respectively. The increase for the three months ended September 30, 2025 is entirely due to the increase in interest income resulting from an increase in cash held in money market accounts and investment securities. Interest income is a function of the level of investments and investment strategies that generally tend to be conservative.   

  

The Company’s effective tax rate for the three months ended September 30, 2025 was approximately 15.2%, compared to approximately 20.0% for the three months ended September 30, 2024. The effective tax rate in fiscal year 2026 is less than the statutory tax rate mainly due to the benefit received from ESOP dividends paid on allocated shares, the benefit from stock-based compensation, and FDII deductions, offset in part by the permanent difference in ESOP fair market value and cost which is not deductible for tax purposes. The effective tax rate for the three months ended September 30, 2025 was lower than the same period in the prior year, primarily due to a greater benefit derived from the ESOP dividends paid on allocated shares and the benefit derived from the exercise of incentive stock options, and the foreign-derived intangible income deduction in the current period when compared to the same period last year. In July 2025, the One Big Beautiful Bill Act (the "Tax Act") was enacted, introducing a series of corporate tax changes in the U.S., including 100% bonus depreciation on qualified property and full expensing for research and development expenditures. The impacts of the Tax Act are reflected in our results for the fiscal quarter ended September 30, 2025, and there was no material impact to our income tax expense or effective tax rate.

 

17 

 

Net income for the three months ended September 30, 2025 was $2,169,836 or $0.80 and $0.76 per share, basic and diluted, compared to net income of $1,598,317 or $0.63 and $0.61 per share, basic and diluted, for the three months ended September 30, 2024. The increase in net income in the three months ended September 30, 2025 when compared to the same period last year resulted primarily from the increase in gross profits, increase in interest income, and a decrease in the provision for income taxes which is slightly offset by an increase in selling, general, and administrative expenses, all discussed above.

 

Liquidity and Capital Resources

 

The Company's working capital is an appropriate indicator of the liquidity of its business. During the past two fiscal years, the Company has funded all of its operations with cash flows resulting from operating activities and when necessary, from its existing cash and investments. The Company did not borrow any funds during the last two fiscal years. Management has a $3,000,000 line of credit available to help fund further growth or working capital needs but does not anticipate the need for any borrowed funds in the foreseeable future. Contingent liabilities on outstanding standby letters of credit agreements aggregated to zero at September 30, 2025 and 2024. The existing line of credit was renewed in February 2025.

 

The Company's working capital as of September 30, 2025 and 2024 was approximately $46.9 million and approximately $38.6 million, respectively. The Company may at times be required to repurchase shares at the ESOP participants’ request at fair market value. During the three months ended September 30, 2025 and 2024, the Company did not repurchase any shares held by the ESOP. Under existing authorizations from the Company's Board of Directors, as of September 30, 2025, management is authorized to purchase an additional $783,460 of Company stock.

 

The table below presents the summary of cash flow information for the fiscal years indicated:

 

   Three Months Ended September 30, 
   2025   2024 
Net cash provided by operating activities  $5,720,090   $1,389,114 
Net cash used in investing activities   (243,436)   (438,769)
Net cash used in financing activities   (2,119,072)   (488,417)

 

Net cash provided by operating activities fluctuates between periods primarily as a result of differences in sales and net income, provision for income taxes, the timing of the collection of accounts receivable, purchase of inventory, and payment of accounts payable. The increase in cash provided by operating activities compared to the prior year primarily relates to an increase in contract liabilities for cash advances received from customers and a decrease in trade accounts receivables. This is offset in part by an increase in inventories, decrease in accrued salaries and wages, and an increase in prepaid expenses and other current assets. Net cash used in investing activities decreased in the three months ended September 30, 2025 as compared to the same period in 2024 due to less purchased investment securities offset in part by proceeds from the maturity of investment securities as well as grant proceeds received when compared to the same period last year. Net cash used in financing activities increased solely due to the increase in dividends paid when compared to the same period last year. The Company currently believes that the cash flow generated from operations and when necessary, from cash and cash equivalents will be sufficient to meet its long-term funding requirements for the foreseeable future.

 

During the three months ended September 30, 2025, the Company expended $1,290,569 for plant improvements and new equipment, of which $1,014,804 was reimbursed under the $3.4 million award received by the Company in the second quarter of fiscal year 2025. During the three months ended September 30, 2024, the Company expended $664,351 for plant improvements and new equipment, of which $595,823 was either reimbursed or eligible to be reimbursed under the $7.4 million award received by the Company in fiscal year 2023. The awards received by the Company are in support of facility and capital equipment upgrades for testing and qualification for the United States Navy. These funding awards are part of the Navy’s investment to improve and sustain the Surface Combatant Industrial Base. The Company has budgeted approximately $850,000 for new equipment and plant improvements in fiscal year 2026, not reimbursable under the funding awards received. A majority of these expenditures will be made to upgrade our facilities, stay competitive in the marketplace, and to meet the needs of current contracts.

 

18 

 

CAUTIONARY STATEMENT FOR PURPOSES OF THE "SAFE HARBOR" PROVISIONS OF THE PRIVATE

SECURITIES LITIGATION REFORM ACT OF 1995

 

This report contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. The terms "believe," "anticipate," "intend," "goal," "expect," and similar expressions may identify forward-looking statements. These forward-looking statements represent the Company's current expectations or beliefs concerning future events. The matters covered by these statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements, including the Company's dependence on timely development, introduction and customer acceptance of new products, the impact of competition and price erosion, supply and manufacturing constraints, potential new orders from customers, the impact of cyber or other security threats or other disruptions to our business, the impact of inflationary pressures on the United States economy and our operations and other risks and uncertainties. The foregoing list should not be construed as exhaustive, and the Company disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events. The Company wishes to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

The Company is a smaller reporting company as defined under Securities and Exchange Commission Rule 12b-2. Pursuant to the exemption available to smaller reporting company issuers under Item 305 of Regulation S-K, quantitative and qualitative disclosures about market risk, the Company is not required to provide the information for this item.

 

Item 4. Controls and Procedures

 

(a) The Company's management, with the participation of the Company's Chief Executive Officer and Principal Financial Officer, carried out an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on such evaluation, our Chief Executive Officer and Principal Financial Officer have concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.

 

(b) There have been no changes in our internal controls over financial reporting during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

 

19 

 

PART II: Other Information and Signatures

 

Item 1.Legal Proceedings

 

Currently, there are no matters pending against the Company which could reasonably be expected to have a material adverse effect on our business, financial condition, results of operations or cash flows.

 

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds

 

(a)Securities Sold

 

(c)Securities Repurchased

 

As of September 30, 2025 the Company can repurchase up to $783,460 of its common stock pursuant to an existing authorization by the Board of Directors. During the quarter ended September 30, 2025 no shares were repurchased.

 

Item 3.Defaults Upon Senior Securities

 

None

 

Item 4.Mine Safety Disclosures

 

Not applicable

 

Item 5.Other Information

 

None

 

Item 6.Exhibits

 

  31.1 Certification of the Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
  31.2 Certification of the Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
  32.1 Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
  32.2 Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

20 

 

 

S I G N A T U R E S

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  ESPEY MFG. & ELECTRONICS CORP.
   
   
  /s/ David O’Neil
  David O’Neil
  President and Chief Executive Officer
   
  /s/ Kaitlyn O’Neil
  Kaitlyn O’Neil
  Principal Financial Officer

 

 

Date: November 12, 2025

 

 

21 

 

0.33 0.33 http://fasb.org/srt/2025#ChiefExecutiveOfficerMember 0000033533 false 2026 Q1 --06-30 0000033533 2025-07-01 2025-09-30 0000033533 2025-11-10 0000033533 2025-09-30 0000033533 2025-06-30 0000033533 2024-07-01 2024-09-30 0000033533 us-gaap:CommonStockMember 2025-06-30 0000033533 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0000033533 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0000033533 us-gaap:RetainedEarningsMember 2025-06-30 0000033533 us-gaap:TreasuryStockCommonMember 2025-06-30 0000033533 esp:UnearnedESOPSharesMember 2025-06-30 0000033533 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0000033533 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-07-01 2025-09-30 0000033533 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0000033533 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0000033533 us-gaap:TreasuryStockCommonMember 2025-07-01 2025-09-30 0000033533 us-gaap:CommonStockMember 2025-09-30 0000033533 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0000033533 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-30 0000033533 us-gaap:RetainedEarningsMember 2025-09-30 0000033533 us-gaap:TreasuryStockCommonMember 2025-09-30 0000033533 esp:UnearnedESOPSharesMember 2025-09-30 0000033533 us-gaap:CommonStockMember 2024-06-30 0000033533 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000033533 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000033533 us-gaap:RetainedEarningsMember 2024-06-30 0000033533 us-gaap:TreasuryStockCommonMember 2024-06-30 0000033533 esp:UnearnedESOPSharesMember 2024-06-30 0000033533 2024-06-30 0000033533 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0000033533 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0000033533 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0000033533 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0000033533 us-gaap:TreasuryStockCommonMember 2024-07-01 2024-09-30 0000033533 us-gaap:CommonStockMember 2024-09-30 0000033533 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0000033533 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0000033533 us-gaap:RetainedEarningsMember 2024-09-30 0000033533 us-gaap:TreasuryStockCommonMember 2024-09-30 0000033533 esp:UnearnedESOPSharesMember 2024-09-30 0000033533 2024-09-30 0000033533 us-gaap:CertificatesOfDepositMember 2025-09-30 0000033533 us-gaap:MunicipalBondsMember 2025-09-30 0000033533 us-gaap:CertificatesOfDepositMember 2025-06-30 0000033533 us-gaap:MunicipalBondsMember 2025-06-30 0000033533 esp:NonQualifiedStockOptionsMember 2025-07-01 2025-09-30 0000033533 esp:NonQualifiedStockOptionsMember 2024-07-01 2024-09-30 0000033533 esp:IncentiveStockOptionMember 2025-09-30 0000033533 esp:NonQualifiedStockOptionsMember 2025-09-30 0000033533 esp:NonEmployeeDirectorsMember esp:TwoThousandSeventeenPlanMember 2025-07-01 2025-09-30 0000033533 srt:MaximumMember esp:NonEmployeeDirectorsMember esp:TwoThousandSeventeenPlanMember 2025-07-01 2025-09-30 0000033533 srt:MaximumMember esp:IndividualEmployeeMember esp:TwoThousandSeventeenPlanMember 2025-07-01 2025-09-30 0000033533 us-gaap:EmployeeStockOptionMember esp:TwoThousandSeventeenPlanMember 2025-07-01 2025-09-30 0000033533 us-gaap:EmployeeStockOptionMember esp:TwoThousandSeventeenPlanMember 2025-09-30 0000033533 us-gaap:EmployeeStockOptionMember 2025-07-01 2025-09-30 0000033533 us-gaap:EmployeeStockOptionMember 2025-09-30 0000033533 esp:RestrictedStockPlanMember esp:TwoThousandSevenPlanMember 2025-07-01 2025-09-30 0000033533 us-gaap:CommonStockMember 2025-09-30 0000033533 us-gaap:StockOptionMember 2024-07-01 0000033533 us-gaap:StockOptionMember 2024-07-01 2024-07-01 0000033533 us-gaap:StockOptionMember 2024-07-01 2024-09-30 0000033533 us-gaap:StockOptionMember 2024-09-30 0000033533 us-gaap:StockOptionMember 2025-07-01 0000033533 us-gaap:StockOptionMember 2025-07-01 2025-07-01 0000033533 us-gaap:StockOptionMember 2025-07-01 2025-09-30 0000033533 us-gaap:StockOptionMember 2025-09-30 0000033533 2024-12-31 0000033533 esp:SurfaceCombatantIndustrialBaseMember 2025-09-30 0000033533 esp:UnitsDeliveredMember esp:ASC606Member 2025-07-01 2025-09-30 0000033533 esp:UnitsDeliveredMember esp:ASC606Member 2024-07-01 2025-06-30 0000033533 esp:MilestonesAchievedMember esp:ASC606Member 2025-07-01 2025-09-30 0000033533 esp:MilestonesAchievedMember esp:ASC606Member 2024-07-01 2025-06-30 0000033533 esp:FiveSignificantCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-07-01 2025-09-30 0000033533 esp:ThreeSignificantCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-07-01 2025-09-30 0000033533 esp:ASC606Member 2025-09-30 0000033533 esp:ASC606Member 2025-06-30 0000033533 esp:ASC606Member us-gaap:OrderOrProductionBacklogMember 2025-09-30 0000033533 esp:EmployeeStockOwnershipPlanMember 2025-06-30 2025-06-30 0000033533 esp:EmployeeStockOwnershipPlanMember 2025-09-30 0000033533 esp:EmployeeStockOwnershipPlanMember 2025-07-01 2025-09-30 0000033533 esp:EmployeeStockOwnershipPlanMember 2024-07-01 2024-09-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure esp:Hour esp:Segment
Espey Mfg & Elec

NYSE:ESP

ESP Rankings

ESP Latest News

ESP Latest SEC Filings

ESP Stock Data

111.77M
2.18M
25.75%
26.36%
0.61%
Electrical Equipment & Parts
Electronic Components, Nec
Link
United States
SARATOGA SPRINGS